Healthcare Law

Abortion Law Patient Rights Reproductive Rights Medical Ethics End-of-Life Legislation Assisted Dying Legislation Assisted Dying Law Euthanasia Law Transgender Rights Regulatory Compliance

FDA Launches Large Safety Study of Mifepristone

Interim results expected as soon as July could influence whether telehealth, mail delivery, or prescriber rules for the abortion pill are tightened.

Stories older than 24h

Feds Finalize Overhaul of No Surprises Act Dispute System

Administration Freezes $1.3 Billion in California Medicaid Payments

Owners Clash in Court Over Control of Closed West Suburban Medical Center

Colorado Supreme Court Orders Children's Hospital to Resume Gender‑Affirming Care

CMS Halts New Medicare Enrollment for Home Health and Hospice Nationwide

Supreme Court to Decide If Title IX Lets School Employees Sue Over Job Bias

Texas Children’s to Open First U.S. Detransition Clinic in $10 Million Settlement

Supreme Court Blocks 5th Circuit, Keeps Abortion Pill Mail Access for Now

CMS Halts New Medicare Enrollment for Hospices and Home Health Agencies Nationwide

Supreme Court Weighs Mifepristone Mail Access as Temporary Stay Nears Deadline

Supreme Court Restores Telehealth and Mail Access to Abortion Pill for Now

Supreme Court Restores Mail and Telehealth Access to Abortion Pill in Temporary Stay

Supreme Court Temporarily Restores Mail and Pharmacy Access to Abortion Pill

Supreme Court Temporarily Restores Mailing of Abortion Pill Mifepristone

Supreme Court Halts Abortion Pill Mail Ban Through May 11

Supreme Court Temporarily Restores Mail and Telehealth Access to Mifepristone

Supreme Court Temporarily Restores Mail and Telehealth Access to Abortion Pill

Appeals Court Blocks Mailed Abortion Pills, Reinstates In-Person Pickup Nationwide

Mifepristone Maker Asks Supreme Court to Restore Mail-Order Prescriptions